Innovation Pharmaceuticals Announces Publication of Scientific Article on the Antifungal Activity of Brilacidin
04 oct. 2022 07h30 HE
|
Innovation Pharmaceuticals Inc
In pre-clinical studies, Brilacidin shown to synergize with marketed antifungals against pathogenic species of aspergillosis, candidiasis, cryptococcosis and mucormycosis, and further exhibited...